>
pdufa.bio

Tenapanor

Updated ยทnext FDA decision on the calendar

Tenapanor is a Ardelyx, Inc. program. Every date links its source.

ARDX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Ardelyx, Inc. (ARDX). We track 3 catalyst events for this program: 0 upcoming and 3 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jun 2026ARDXReadout · Jul 2026ARDXReadout · Sep 2026ARDX

Questions

When is Tenapanor's next FDA decision or readout?

No upcoming catalyst is on our calendar for Tenapanor; no FDA decisions are on record below.

What happened at Tenapanor's most recent FDA decision?

No FDA decision for Tenapanor is in our archive yet.

Who makes Tenapanor?

Ardelyx, Inc. (ARDX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.